FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer
NCT03161574
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
No participants were recruited
Conditions
Rectal Cancer
Interventions
DRUG:
FOLFOXIRI
Sponsor
Guangxi Medical University